NFKB1 and metabolic dysfunction-associated steatohepatitis: In models of non-alcoholic steatohepatitis (NASH), caffeine ameliorated hepatic inflammation by downregulating TLR4/MAPK/NF-κB signaling and suppressing NLRP3 inflammasome activation (94).